The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys

Experimental Neurology

Volumn 228, Issue 1, 2011, Pages 53-58

  Gilmour, Timothy P ^a,b   Lieu, Christopher A ^a   Nolt, Mark J ^a,c   Piallat, Brigitte ^d   Deogaonkar, Milind ^e   Subramanian, Thyagarajan ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b The Pennsylvania State University   (United States)

^c Functional Neurosurgical Services   (United States)

^d GRENOBLE INSTITUT DES NEUROSCIENCES   (France)

^e LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Basal ganglia; Electrophysiology; Levodopa; LFP; Macaca mulatta; MPTP; Neuronal bursting; Nigrostriatal degeneration; Nonmotor symptoms; Parkinson's disease

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; CARBIDOPA PLUS LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DRUG DOSE ESCALATION; DRUG INTERMITTENT THERAPY; DYSKINESIA; ELECTRIC POTENTIAL; ENTROPY; FEMALE; INTRACELLULAR RECORDING; MOTOR DYSFUNCTION; NERVE CELL STIMULATION; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL; RHESUS MONKEY; SPIKE WAVE; SUBSTANTIA NIGRA PARS RETICULATA; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

ACTION POTENTIALS; ANIMALS; FEMALE; LEVODOPA; MACACA MULATTA; NEURONS; PARKINSONIAN DISORDERS; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 79851509222     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2010.12.001     Document Type: Article

References (50)

1. Albin R.L., et al. The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989, 12(10):366-375.
2. Aldridge J.W., Gilman S. The temporal structure of spike trains in the primate basal ganglia: afferent regulation of bursting demonstrated with precentral cerebral cortical ablation. Brain Res. 1991, 543(1):123-138.
3. Alonso-Frech F., et al. Slow oscillatory activity and levodopa-induced dyskinesias in Parkinson's disease. Brain 2006, 129(Pt 7):1748-1757.
4. Arbuthnott G., Garcia-Munoz M. Dealing with the devil in the detail-some thoughts about the next model of the basal ganglia. Parkinsonism Relat. Disord. 2009, 15(Suppl 3):S139-S142.
5. Bejjani B.P., et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J. Neurosurg. 2000, 92(4):615-625.
6. Bergman H., et al. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J. Neurophysiol. 1994, 72(2):507-520.
7. Boraud T., et al. Effects of L-DOPA on neuronal activity of the globus pallidus externalis (GPe) and globus pallidus internalis (GPi) in the MPTP-treated monkey. Brain Res. 1998, 787(1):157-160.
8. Breit S., et al. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal activity of the pedunculopontine nucleus, which is reversed by the lesion of the subthalamic nucleus in the rat. Eur. J. Neurosci. 2001, 14(11):1833-1842.
9. Breit S., et al. Lesion of the pedunculopontine nucleus reverses hyperactivity of the subthalamic nucleus and substantia nigra pars reticulata in a 6-hydroxydopamine rat model. Eur. J. Neurosci. 2006, 24(8):2275-2282.
10. Breit S., et al. Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat. Exp. Neurol. 2007, 205(1):36-47.
11. Brown P., et al. Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J. Neurosci. 2001, 21(3):1033-1038.
12. Brown P., et al. Oscillatory local field potentials recorded from the subthalamic nucleus of the alert rat. Exp. Neurol. 2002, 177(2):581-585.
13. Darbin O., et al. Nonlinear analysis of discharge patterns in monkey basal ganglia. Brain Res. 2006, 1118(1):84-93.
14. DeLong M.R. Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 1990, 13(7):281-285.
15. Fahn S. Does levodopa slow or hasten the rate of progression of Parkinson's disease?. J. Neurol. 2005, 252(Suppl. 4):IV37-IV42.
16. Galvan A., Wichmann T. Pathophysiology of parkinsonism. Clin. Neurophysiol. 2008, 119(7):1459-1474.
17. Gatev P., et al. Oscillations in the basal ganglia under normal conditions and in movement disorders. Mov. Disord. 2006, 21(10):1566-1577.
18. Giannicola G., et al. The effects of levodopa and ongoing deep brain stimulation on subthalamic beta oscillations in Parkinson's disease. Exp. Neurol. 2010, 226(1):120-127.
19. Gradinaru V., et al. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324(5925):354-359.
20. Hammond C., et al. Pathological synchronization in Parkinson's disease: networks, models and treatments. Trends Neurosci. 2007, 30(7):357-364.
21. Hutchison W.D., et al. Effects of apomorphine on globus pallidus neurons in parkinsonian patients. Ann. Neurol. 1997, 42(5):767-775.
22. Hutchison W.D., et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann. Neurol. 1998, 44(4):622-628.
23. Kaneoke Y., Vitek J.L. Burst and oscillation as disparate neuronal properties. J. Neurosci. Meth. 1996, 68(2):211-223.
24. Kliem M.A., et al. Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys. J. Neurophysiol. 2007, 98(3):1489-1500.
25. Kreiss D.S., et al. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J. Neurosci. 1997, 17(17):6807-6819.
26. Kuhn A.A., et al. Reduction in subthalamic 8-35Hz oscillatory activity correlates with clinical improvement in Parkinson's disease. Eur. J. Neurosci. 2006, 23(7):1956-1960.
27. Lafreniere-Roula, M., et al. "Apomorphine reduces subthalamic neuronal entropy in parkinsonian patients." Exp Neurol 2010;225(2):455-8.
28. Legendy C.R., Salcman M. Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons. J. Neurophysiol. 1985, 53(4):926-939.
29. Levy R., et al. High-frequency synchronization of neuronal activity in the subthalamic nucleus of parkinsonian patients with limb tremor. J. Neurosci. 2000, 20(20):7766-7775.
30. Levy R., et al. Effects of apomorphine on subthalamic nucleus and globus pallidus internus neurons in patients with Parkinson's disease. J. Neurophysiol. 2001, 86(1):249-260.
31. Lieu C.A., et al. Dyskinesias do not develop after chronic intermittent levodopa therapy in clinically hemiparkinsonian rhesus monkeys. Parkinsonism Relat. Disord. 2011, 17(1):34-39.
32. Lopez-Azcarate J., et al. Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease. J. Neurosci. 2010, 30(19):6667-6677.
33. Lozano A.M., et al. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine. Ann. Neurol. 2000, 47(4 Suppl. 1):S141-S146.
34. Magnin M., et al. Single-unit analysis of the pallidum, thalamus and subthalamic nucleus in parkinsonian patients. Neuroscience 2000, 96(3):549-564.
35. Mallet N., et al. Disrupted dopamine transmission and the emergence of exaggerated beta oscillations in subthalamic nucleus and cerebral cortex. J. Neurosci. 2008, 28(18):4795-4806.
36. Moran A., et al. Real-time refinement of subthalamic nucleus targeting using Bayesian decision-making on the root mean square measure. Mov. Disord. 2006, 21(9):1425-1431.
37. Nevet A., et al. Discharge rate of substantia nigra pars reticulata neurons is reduced in non-parkinsonian monkeys with apomorphine-induced orofacial dyskinesia. J. Neurophysiol. 2004, 92(4):1973-1981.
38. Newman E.J., et al. The parkinsonism-hyperpyrexia syndrome. Neurocrit. Care 2009, 10(1):136-140.
39. Park Y.S., et al. Lesion of subthalamic nucleus in parkinsonian rats: effects of dopamine d(1) and d(2) receptor agonists on the neuronal activities of the substantia nigra pars reticulata. J. Korean Neurosurg. Soc. 2007, 42(6):455-461.
40. Pincus S.M. Approximate entropy as a measure of system complexity. Proc. Natl Acad. Sci. USA 1991, 88(6):2297-2301.
41. Prescott I.A., et al. Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients. Brain 2009, 132(Pt 2):309-318.
42. Richman J.S., Moorman J.R. Physiological time-series analysis using approximate entropy and sample entropy. Am. J. Physiol. Heart Circ. Physiol. 2000, 278(6):H2039-H2049.
43. Sharott A., et al. Dopamine depletion increases the power and coherence of beta-oscillations in the cerebral cortex and subthalamic nucleus of the awake rat. Eur. J. Neurosci. 2005, 21(5):1413-1422.
44. Snellings A., et al. Identification of the subthalamic nucleus in deep brain stimulation surgery with a novel wavelet-derived measure of neural background activity. J. Neurosurg. 2009, 111(4):767-774.
45. Starr P.A., et al. Electrophysiological localization of the substantia nigra in the parkinsonian nonhuman primate. J. Neurosurg. 2000, 93(4):704-710.
46. Subramanian T., et al. Detection of MPTP-induced substantia nigra hyperechogenicity in Rhesus monkeys by transcranial ultrasound. Ultrasound Med. Biol. 2010, 36(4):604-609.
47. Theodosopoulos P.V., et al. Locations of movement-related cells in the human subthalamic nucleus in Parkinson's disease. Mov. Disord. 2003, 18(7):791-798.
48. Weinberger M., et al. Pathological subthalamic nucleus oscillations in PD: can they be the cause of bradykinesia and akinesia?. Exp. Neurol. 2009, 219(1):58-61.
49. Wichmann T., Soares J. Neuronal firing before and after burst discharges in the monkey basal ganglia is predictably patterned in the normal state and altered in parkinsonism. J. Neurophysiol. 2006, 95(4):2120-2133.
50. Wichmann T., et al. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp. Brain Res. 1999, 125(4):397-409.